ETS2 and hepatocellular carcinoma: Thus, we conclude that both the rs2853669 variant (the co-target of E2F1 and ETS2) and −124C > T mutation (the ETS2 target) are involved in the modulation of methylation at the TERT promoter and further increased the TERT expression in HCC cells.